Water → 5-((2Z)-2-((1-(difluoroboryl)-3,5-dimethyl-1H-pyrrol-2-yl)methylene)-2H-pyrrol-5-yl)-N-(2-((3,5-difluoro-4-(trimethylsilyl)phenyl)amino)-1-(4-(methoxymethyl)phenyl)-2-oxoethyl)pentanamide

HRID 2202335ノート

反応式

HRID 2202335 の反応式
[NH2:1][CH:2]([C:18]1[CH:23]=[CH:22][C:21]([CH2:24][O:25][CH3:26])=[CH:20][CH:19]=1)[C:3]([NH:5][C:6]1[CH:11]=[C:10]([F:12])[C:9]([Si:13]([CH3:16])([CH3:15])[CH3:14])=[C:8]([F:17])[CH:7]=1)=[O:4].[F:27][B:28]([F:56])[N:29]1[C:33]([CH3:34])=[CH:32][C:31]([CH3:35])=[C:30]1/[CH:36]=[C:37]1\[N:38]=[C:39]([CH2:42][CH2:43][CH2:44][CH2:45][C:46](ON2C(=O)CCC2=O)=[O:47])[CH:40]=[CH:41]\1.O.O.C(#N)C>CN(C=O)C>[F:56][B:28]([F:27])[N:29]1[C:33]([CH3:34])=[CH:32][C:31]([CH3:35])=[C:30]1/[CH:36]=[C:37]1\[N:38]=[C:39]([CH2:42][CH2:43][CH2:44][CH2:45][C:46]([NH:1][CH:2]([C:18]2[CH:19]=[CH:20][C:21]([CH2:24][O:25][CH3:26])=[CH:22][CH:23]=2)[C:3]([NH:5][C:6]2[CH:11]=[C:10]([F:12])[C:9]([Si:13]([CH3:14])([CH3:15])[CH3:16])=[C:8]([F:17])[CH:7]=2)=[O:4])=[O:47])[CH:40]=[CH:41]\1

参加物

6

反応物 4

HCID 962WaterHCID 103646301-((5-((2Z)-2-((1-(difluoroboryl)-3,5-dimethyl-1H-pyrrol-2-yl)methylene)-2H-pyrrol-5-yl)pentanoyl)oxy)pyrrolidine-2,5-dioneHCID 18373917Acetonitrile--water (1/1)HCID 1317357652-amino-N-(3,5-difluoro-4-(trimethylsilyl)phenyl)-2-(4-(methoxymethyl)phenyl) acetamide

生成物 1

HCID 1317357665-((2Z)-2-((1-(difluoroboryl)-3,5-dimethyl-1H-pyrrol-2-yl)methylene)-2H-pyrrol-5-yl)-N-(2-((3,5-difluoro-4-(trimethylsilyl)phenyl)amino)-1-(4-(methoxymethyl)phenyl)-2-oxoethyl)pentanamide収率 55.8%

試薬・触媒・溶媒 1

HCID 6228Dimethylformamide溶媒

実験手順

To a solution of the crude 2-amino-N-(3,5-difluoro-4-(trimethylsilyl)phenyl)-2-(4-(methoxymethyl)phenyl)acetamide (9.07 mg, 0.02 mmol) in DMF (0.5 mL) was added 1-((5-((2Z)-2-((1-(difluoroboryl)-3,5-dimethyl-1H-pyrrol-2-yl)methylene)-2H-pyrrol-5-yl)pentanoyl)oxy)pyrrolidine-2,5-dione (BODIPY (registered trademark) FL-C5 succinimidyl ester) (5.0 mg, 0.01 mmol) at room temperature, and the mixture was stirred at room temperature for 3 hr. To the reaction mixture was added water, and the mixture was extracted with ethyl acetate. The organic layer was washed with water and brine, and dried over magnesium sulfate, and the solvent was evaporated under reduced pressure. The obtained residue was purified by silica gel column chromatography (solvent; ethyl acetate/hexane), and then preparative HPLC (C18, mobile phase: water/acetonitrile (containing 0.1% TFA)) to give 5-((2Z)-2-((1-(difluoroboryl)-3,5-dimethyl-1H-pyrrol-2-yl)methylene)-2H-pyrrol-5-yl)-N-(2-((3,5-difluoro-4-(trimethylsilyl)phenyl)amino)-1-(4-(methoxymethyl)phenyl)-2-oxoethyl)pentanamide (3.8 mg, 5.58 μmol, 46.6%) as an orange solid, which is a fluorescent-labeled synthetic ligand.

後処理

  1. extractionthe mixture was extracted with ethyl acetate
  2. washThe organic layer was washed with water and brine
  3. dry with materialdried over magnesium sulfate
  4. customthe solvent was evaporated under reduced pressure
  5. customThe obtained residue was purified by silica gel column chromatography (solvent; ethyl acetate/hexane)

出典と根拠

ORDレコード
ord-241b26c5805c4fc692e8b5a386553aa5
出典データセット
uspto-grants-2016_06
特許番号
US09365520B2

反応ノート

読み込み中…